REQUEST A DEMO
Total
USD $0.00
Search more companies

HLB bioStep Co. Ltd. (South Korea)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences | Medical and Diagnostic Laboratories
Full name: HLB bioStep Co. Ltd. Profile Updated: June 19, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

HLB bioStep Co. Ltd. is an enterprise based in South Korea. Its main office is in Incheon. It operates in the Research and Development in the Physical, Engineering, and Life Sciences industry. The enterprise was incorporated on April 19, 2012. It currently has a total number of 178 (2023) employees. There was a net sales revenue increase of 20.49% reported in HLB bioStep Co. Ltd.’s latest financial highlights for 2022. There was a total growth of 82.06% in HLB bioStep Co. Ltd.’s total assets over the same period.

Headquarters
38, Academy-Ro 79Beon-Gil, Yeonsu-Gu
Incheon; Incheon;

Contact Details: Purchase the HLB bioStep Co. Ltd. report to view the information.

Website: http://www.knotus.co.kr

Basic Information
Total Employees:
Purchase the HLB bioStep Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the HLB bioStep Co. Ltd. report to view the information.
Registered Capital:
Purchase the HLB bioStep Co. Ltd. report to view the information.
Financial Auditors:
Purchase the HLB bioStep Co. Ltd. report to view the information.
Incorporation Date:
April 19, 2012
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Company Performance
Financial values in the chart are available after HLB bioStep Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
20.49%
Total Operating Revenue
20.49%
Operating Profit
-34.42%
EBITDA
-17.56%
Net Profit/Loss for the Period
N/A
Total Assets
82.06%
Total Equity
5.35%
Operating Profit Margin
-8.29%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
111817%
Quick Ratio
9853.27%
Cash Ratio
1.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?